<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02382757</url>
  </required_header>
  <id_info>
    <org_study_id>INS-3982</org_study_id>
    <secondary_id>U1111-1149-2666</secondary_id>
    <nct_id>NCT02382757</nct_id>
  </id_info>
  <brief_title>Changing Diabetes in Children</brief_title>
  <acronym>CDiC</acronym>
  <official_title>Changing Diabetes in Children (CDiC): Type 1 Diabetes in Economically Underprivileged Children in India</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Novo Nordisk A/S</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Novo Nordisk A/S</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is conducted in Asia. The primary objective of the CDiC programme is to improve
      access to comprehensive diabetes care among the children with diabetes from the economically
      underprivileged section of the population and to establish a registry for this group of
      children with type 1 diabetes in India.
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <start_date>September 2011</start_date>
  <completion_date type="Actual">November 2012</completion_date>
  <primary_completion_date type="Actual">November 2012</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Patient assessments: Number of days on insulin</measure>
    <time_frame>After 40 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of days with home blood glucose monitoring</measure>
    <time_frame>After 40 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>HbA1c (glycosylated haemoglobin)</measure>
    <time_frame>After 40 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of episodes of ketoacidosis</measure>
    <time_frame>After 40 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of episodes of severe hypoglycaemia</measure>
    <time_frame>After 40 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Long-term complications</measure>
    <time_frame>After 40 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Percentage of children with HbA1c equal to or below 8.0</measure>
    <time_frame>After 40 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of children who died during the study</measure>
    <time_frame>After 40 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of children lost to follow-up</measure>
    <time_frame>After 40 months</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">3089</enrollment>
  <condition>Diabetes</condition>
  <condition>Diabetes Mellitus, Type 1</condition>
  <arm_group>
    <arm_group_label>Children</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>insulin human</intervention_name>
    <description>Children will receive conventional treatment with human insulin according to standard medical practice.</description>
    <arm_group_label>Children</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Children with type 1 diabetes aged below 18 years will be included.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Children diagnosed with type 1 diabetes

          -  Parents/caretakers agree to participate in the study

          -  Child belongs to the below poverty line economic strata (Centre Director certifies
             economic status for inclusion in to the study)

        Exclusion Criteria:

          -  Children with type 2 diabetes

          -  Children from higher economic status

          -  Those getting coverage under other government / private schemes
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Global Clinical Registry (GCR, 1452)</last_name>
    <role>Study Director</role>
    <affiliation>Novo Nordisk A/S</affiliation>
  </overall_official>
  <location>
    <facility>
      <address>
        <city>Bangalore</city>
        <zip>560001</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>India</country>
  </location_countries>
  <link>
    <url>http://novonordisk-trials.com</url>
    <description>Clinical Trials at Novo Nordisk</description>
  </link>
  <verification_date>February 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 3, 2015</study_first_submitted>
  <study_first_submitted_qc>March 3, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 9, 2015</study_first_posted>
  <last_update_submitted>March 3, 2015</last_update_submitted>
  <last_update_submitted_qc>March 3, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 9, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 1</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Insulin, Globin Zinc</mesh_term>
    <mesh_term>Insulin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

